Pharmacogenomics Variation in Drug Metabolizing Enzymes and Transporters in Relation to Docetaxel Toxicity in Lebanese Breast Cancer Patients: Paving the Way for OMICs in Low and Middle Income Countries

2013 ◽  
Vol 17 (7) ◽  
pp. 353-367 ◽  
Author(s):  
Zainab Awada ◽  
Syed Haider ◽  
Arafat Tfayli ◽  
Ali Bazarbachi ◽  
Nagi S. El-Saghir ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Drug Metabolizing Enzymes ◽  
Breast Cancer Patients ◽  
Metabolizing Enzymes ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income ◽  
The Way

scholarly journals The experiences of family caregivers living with breast cancer patients in low-and middle-income countries: a systematic review

2020 ◽  
Vol 9 (1) ◽  
Author(s):  
Grace Kusi ◽  
Adwoa Bemah Boamah Mensah ◽  
Kofi Boamah Mensah ◽  
Veronica Millicent Dzomeku ◽  
Felix Apiribu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Cancer Patients ◽  
Family Caregivers ◽  
Breast Cancer Patients ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income

scholarly journals Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic

2020 ◽  
Vol 16 (31) ◽  
pp. 2551-2567 ◽  
Author(s):  
Hagar Elghazawy ◽  
Joaira Bakkach ◽  
Mohamed S Zaghloul ◽  
Atlal Abusanad ◽  
Mariam Mohamed Hussein ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Continuum Of Care ◽  
Global Perspective ◽  
Breast Cancer Patients ◽  
Middle Income ◽  
Middle Income Countries ◽  
Clinical Scenarios ◽  
Team Setting ◽  
Common Malignancy ◽  
Low And Middle Income

Breast cancer is the most common malignancy among women worldwide. The current COVID-19 pandemic represents an unprecedented challenge leading to care disruption, which is more severe in low- and middle-income countries (LMIC) due to existing economic obstacles. This review presents the global perspective and preparedness plans for breast cancer continuum of care amid the COVID-19 outbreak and discusses challenges faced by LMIC in implementing these strategies. Prioritization and triage of breast cancer patients in a multidisciplinary team setting are of paramount importance. Deescalation of systemic and radiation therapy can be utilized safely in selected clinical scenarios. The presence of a framework and resource-adapted recommendations exploiting available evidence-based data with judicious personalized use of current resources is essential for breast cancer care in LMIC during the COVID-19 pandemic.

scholarly journals Breast Cancer in Low- and Middle-Income Countries: An Emerging and Challenging Epidemic

2010 ◽  
Vol 2010 ◽  
pp. 1-5 ◽  
Author(s):  
Arafat Tfayli ◽  
Sally Temraz ◽  
Rachel Abou Mrad ◽  
Ali Shamseddine
Keyword(s):  
Breast Cancer ◽  
Health Care ◽  
Low Income ◽  
Therapeutic Interventions ◽  
Low Income Countries ◽  
Middle Income ◽  
Major Health ◽  
Middle Income Countries ◽  
Low And Middle Income

Breast cancer is a major health care problem that affects more than one million women yearly. While it is traditionally thought of as a disease of the industrialized world, around 45% of breast cancer cases and 55% of breast cancer deaths occur in low and middle income countries. Managing breast cancer in low income countries poses a different set of challenges including access to screening, stage at presentation, adequacy of management and availability of therapeutic interventions. In this paper, we will review the challenges faced in the management of breast cancer in low and middle income countries.

scholarly journals Breast Cancer in Low- and Middle-Income Countries

2018 ◽  
Vol 38 (1) ◽  
pp. 161-173 ◽  
Author(s):  
Yehoda M. Martei ◽  
Lydia E. Pace ◽  
Jane E. Brock ◽  
Lawrence N. Shulman
Keyword(s):  
Breast Cancer ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income
Sign in / Sign up

Export Citation Format

Share Document